US 9120746
Crystalline form of a 3-phenoxymethylpyrrolidine compound
granted A61KA61K31/40A61K45/06
Quick answer
US patent 9120746 (Crystalline form of a 3-phenoxymethylpyrrolidine compound) held by Theravance Biopharma R&D IP, LLC expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/40, A61K45/06, A61P, A61P13/00